IMMUNOTHERAPY OF EXPERIMENTAL MYASTHENIA-GRAVIS - SELECTIVE EFFECTS OF CTLA4IG AND SYNERGISTIC COMBINATION WITH AN IL-2 DIPHTHERIA-TOXIN FUSION PROTEIN
Db. Drachman et al., IMMUNOTHERAPY OF EXPERIMENTAL MYASTHENIA-GRAVIS - SELECTIVE EFFECTS OF CTLA4IG AND SYNERGISTIC COMBINATION WITH AN IL-2 DIPHTHERIA-TOXIN FUSION PROTEIN, Annals of neurology, 42(3), 1997, pp. 229-229